ARCLIGHT CLEAN TRANSITION -A (ACTD) Fundamental Analysis & Valuation

NASDAQ:ACTD • KYG0R21B1044

Current stock price

7.6 USD
-0.22 (-2.81%)
At close:
7.95 USD
+0.35 (+4.61%)
After Hours:

This ACTD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ACTD Profitability Analysis

1.1 Basic Checks

  • ACTD had negative earnings in the past year.
ACTD Yearly Net Income VS EBIT VS OCF VS FCFACTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -3.84%
ROE N/A
ROIC -1.57%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACTD Yearly ROA, ROE, ROICACTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 -1 -2 -3 -4 -5

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ACTD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACTD Yearly Profit, Operating, Gross MarginsACTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ACTD Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACTD is destroying value.
  • There is no outstanding debt for ACTD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ACTD Yearly Shares OutstandingACTD Yearly Shares OutstandingYearly Shares Outstanding 2021 10M 20M 30M
ACTD Yearly Total Debt VS Total AssetsACTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 100M 200M 300M

2.2 Solvency

  • ACTD has an Altman-Z score of 4.64. This indicates that ACTD is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for ACTD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.64
ROIC/WACC-0.18
WACC8.71%
ACTD Yearly LT Debt VS Equity VS FCFACTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 6.50 indicates that ACTD has no problem at all paying its short term obligations.
  • A Quick Ratio of 6.50 indicates that ACTD has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 6.5
Quick Ratio 6.5
ACTD Yearly Current Assets VS Current LiabilitesACTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 500K 1M 1.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ACTD Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1176.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ACTD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 87.01% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y166.47%
EPS Next 2Y110.48%
EPS Next 3Y75.51%
EPS Next 5Y87.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACTD Yearly Revenue VS EstimatesACTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 1B 2B 3B
ACTD Yearly EPS VS EstimatesACTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. ACTD Valuation Analysis

4.1 Price/Earnings Ratio

  • ACTD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • ACTD is valuated cheaply with a Price/Forward Earnings ratio of 6.37.
  • ACTD is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.37
ACTD Price Earnings VS Forward Price EarningsACTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACTD Per share dataACTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ACTD's earnings are expected to grow with 75.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y110.48%
EPS Next 3Y75.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACTD Dividend Analysis

5.1 Amount

  • ACTD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ACTD Fundamentals: All Metrics, Ratios and Statistics

ARCLIGHT CLEAN TRANSITION -A

NASDAQ:ACTD (7/21/2022, 8:00:00 PM)

After market: 7.95 +0.35 (+4.61%)

7.6

-0.22 (-2.81%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-16
Earnings (Next)N/A
Inst Owners1.05%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap295.60M
Revenue(TTM)N/A
Net Income(TTM)-11.99M
Analysts85.71
Price Target20.4 (168.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.37
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)1.19
Fwd EY15.7%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.1
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.84%
ROE N/A
ROCE N/A
ROIC -1.57%
ROICexc N/A
ROICexgc -1.57%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.5
Quick Ratio 6.5
Altman-Z 4.64
F-Score4
WACC8.71%
ROIC/WACC-0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1176.25%
EPS Next Y166.47%
EPS Next 2Y110.48%
EPS Next 3Y75.51%
EPS Next 5Y87.01%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ARCLIGHT CLEAN TRANSITION -A / ACTD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ARCLIGHT CLEAN TRANSITION -A (ACTD) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACTD.


What is the valuation status of ARCLIGHT CLEAN TRANSITION -A (ACTD) stock?

ChartMill assigns a valuation rating of 5 / 10 to ARCLIGHT CLEAN TRANSITION -A (ACTD). This can be considered as Fairly Valued.


What is the profitability of ACTD stock?

ARCLIGHT CLEAN TRANSITION -A (ACTD) has a profitability rating of 1 / 10.


Can you provide the financial health for ACTD stock?

The financial health rating of ARCLIGHT CLEAN TRANSITION -A (ACTD) is 4 / 10.


What is the expected EPS growth for ARCLIGHT CLEAN TRANSITION -A (ACTD) stock?

The Earnings per Share (EPS) of ARCLIGHT CLEAN TRANSITION -A (ACTD) is expected to grow by 166.47% in the next year.